Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3686 (MIR3686)
- Target
- MIR3686
- Molecular classification
- MicroRNA, Non-coding RNA, Regulatory RNA
01
Overview
MicroRNA 3686 is a human non-coding RNA gene that produces a mature microRNA (miRNA) molecule through Drosha and Dicer-dependent biogenesis. Mature miRNAs are short (~20–24 nt) and function by joining the RNA-induced silencing complex (RISC) to regulate gene expression post-transcriptionally, typically by base-pairing with the 3' UTR of target mRNAs and consequently inhibiting translation or promoting mRNA degradation. The gene is annotated in several genomic databases (HGNC:38887, NCBI Gene:100500839, Ensembl:ENSG00000263763, miRBase:hsa-mir-3686)[1]. While miRNAs are implicated in a broad range of developmental and disease-related processes, no specific function or disease link has been established in the current scientific literature for MIR3686. MicroRNAs are increasingly studied as biomarkers and therapeutic molecules but MIR3686 itself is not presently a recognized clinical target[1][3][5][6].
- Other names
- MIR3686hsa-mir-3686miR-3686
02
Mechanism of action
N/A (Drugs do not conventionally *target* miRNAs themselves, but miRNAs regulate genes, and their mechanisms include: - Translational inhibition - mRNA destabilization - mRNA cleavage)
03
Biological functions
Post-transcriptional regulation of gene expressionInhibition of mRNA translationDestabilization/degradation of target mRNARegulation of cell proliferation, differentiation, survival, apoptosis, immune response, and development (processes suggested for many microRNAs, though specific functions for MIR3686 require experimental evidence)
04
Disease associations
Other (General involvement of microRNAs in diseases such as cancer, cardiovascular, and neurodegenerative disease is well-documented, but no specific link for MIR3686 found in current results)
05
Safety considerations
Other (Therapeutic use of miRNA mimics or inhibitors may raise toxicity/off-target concerns; not specific for MIR3686)
06
Interacting drugs
None known (miRNAs generally regulate gene expression; direct pharmacological targeting of specific miRNAs is experimental and uncommon as of current literature)
07
Biomarkers
Other (miRNAs can serve as biomarkers for disease or therapeutic response in principle, via detection in blood or fluids, but no published evidence for MIR3686 specific use)
Beyond the preview
Go deeper on MicroRNA 3686 (MIR3686).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MicroRNA 3686 (MIR3686).